What Baxter's latest 10-Q says: 10 signals
Baxter filed its latest 10-Q with the SEC on Jul 30, 2026. It discusses cash flow concern, compliance burden and cybersecurity incident.
Public (BAX)Medical Equipment Manufacturing10,000+ employeesbaxter.comLinkedIn
- Filed
- Jul 30, 2026
- Filings
- 2
- Signals
- 22
10-Q · latest 10
What Baxter's 10-Q filings say
- SEC EDGAR
10-Q
Filed · 10 signals
Baxter reports experiencing IT system breakdowns from obsolescence and cyber breaches.
The company has experienced failures in its IT systems, explicitly citing obsolescence, cyber breaches, and data leakage as causes.
artificial intelligence (AI)machine learning
The company is incurring significant costs for employee severance and contract terminations as part of ongoing optimization programs.
Baxter addresses FDA Warning Letter at India plant and notes quality issues with Novum LVP product.
The company recently resolved a 2023 FDA Warning Letter at its Ahmedabad, India facility, indicating intense focus on manufacturing and quality compliance.
Baxter acknowledges experiencing past cybersecurity breaches and data leakage incidents.
The company explicitly states it has experienced cybersecurity breaches and data leakage, creating significant operational and reputational risk.
IT system 'obsolescence' cited as a cause for breakdowns and security breaches at Baxter.
Baxter identifies system 'obsolescence' as a direct cause of IT breakdowns and security vulnerabilities.
Baxter flags $1.51B in goodwill for its Front Line Care unit as at risk for future impairment.
The company is closely monitoring the performance of its Front Line Care unit due to macroeconomic conditions and capital spending patterns.
$1.5B
Carrying amount of goodwill for the Front Line Care reporting unit at risk of impairment
Significant indebtedness constrains Baxter's ability to fund growth strategies and R&D.
Baxter's substantial debt requires a large portion of its cash flow for debt service, limiting investment in strategic initiatives.
Baxter managing operational complexity and risks following the sale of its Kidney Care business.
Divesting a major business unit creates significant operational and IT challenges, including separating systems, data, and processes.
A manufacturing facility in Ahmedabad, India received multiple FDA warning letters (2017, 2023), indicating long-standing quality control challenges.
Baxter actively incorporating AI and machine learning into products and operations.
The company is strategically investing in AI and machine learning, indicating a need for advanced data infrastructure, specialized talent, and new technology platforms.
AImachine learning
Earlier 10-Q filings
- 10-QFiled · 12 signalsSEC EDGAR
Showing 10 of 22 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Baxter earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Product issues are causing customers to evaluate competitor infusion pumps.The company explicitly acknowledges that the delay in resolving the Novum IQ pump issue is leading customers to evaluate alternative solutions, signaling a direct risk of market share loss. This makes Baxter highly receptive to solutions that can help retain customers or improve their competitive positioning. | |
| Launching new 'data-driven' growth and performance system (GPS).New CEO Andrew Hider is rolling out a company-wide, data-driven system called 'Baxter GPS' to drive continuous improvement and a performance mindset. This creates significant opportunities for vendors specializing in analytics, business intelligence, performance management software, and operational excellence consulting. | |
| Lowered full-year 2025 operational sales and earnings guidance.The company reduced its operational sales growth forecast from 3-4% to 1-2% and lowered its EPS guidance, citing challenges with infusion pumps and product softness. This financial pressure makes them more receptive to solutions that can drive efficiency, cut costs, or recover revenue. | |
| Cutting dividend to free up over $300M annually for aggressive deleveraging.Baxter is prioritizing balance sheet strength by reducing its dividend to accelerate deleveraging, aiming for a 3x net leverage target by the end of 2026. This sharp focus on financial health signals a need for cost-control measures, financial planning software, and efficiency-driving solutions to maximize cash flow. | |
| Facing margin pressure from increased manufacturing, supply, and procurement costs.The company is experiencing higher costs across its supply chain, which is negatively impacting operating margins in both the Medical Products and Pharmaceuticals segments. This creates an urgent need for solutions that can optimize supply chain logistics, reduce manufacturing overhead, or improve procurement efficiency. | |
| Cutting dividend to free up over $300M annually for debt reduction.The company is taking decisive action to strengthen its balance sheet by cutting its dividend, freeing up significant cash flow explicitly for deleveraging. This signals a strong focus on financial discipline and cost control over expansive new spending initiatives. |
Signal API · MCP
Track Baxter with the Signal API
One POST /v1/companies/enrich call with baxter.com returns Baxter 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"baxter.com","signal_types":["sec-10q"],"limit":20}'Same industry
10-Q at related companies
Questions about Baxter 10-Q
When did Baxter file its latest 10-Q?
What did Baxter disclose in its latest 10-Q?
What did Baxter say on its recent earnings calls?
Where can I read Baxter's 10-Q filing?
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .